Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PISCES I: Precision Implemented Smoking Cessation Evaluation Study

NCT04604509 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04604509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04604509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PISCES I: Precision Implemented Smoking Cessation Evaluation Study
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 4
Overall status
Recruiting
Start date
August 4, 2020
Completion date
December 31, 2028
Enrollment
2,010 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoking-related carcinoma